Verona are in talks for Venezia defender Fali Candè, while Cagliari have met Inter for Sebastiano Esposito, but Fiorentina ...

Merck said on Wednesday it will acquire UK-based Verona Pharma for about $10 billion, gaining a promising respiratory ...

Merck’s recent acquisition announcement sends a strong signal regarding its urgency to tackle the impending Keytruda patent ...

Pharmaceutical giant Merck is buying Verona Pharma, a company that concentrates its efforts on respiratory diseases, in an ...

The move bolsters Merck’s lineup as it braces for the 2028 loss of patent exclusivity for blockbuster cancer drug Keytruda.

Fiorentina are set to win the race to sign Inter Milan striker Sebastiano Esposito ahead of Cagliari and Hellas Verona.This ...

Merck is nearing a $10 billion deal to buy lung diseases focussed Verona Pharma, as the U.S. drugmaker is eyeing deals to ...

Verona officials will soon be in the market for a new manager. Stefanie Woolford resigned from her position during Tuesday ...

The New Jersey-based pharma has inked one of the biggest deals of the year in pursuit of a promising new way to treat COPD.

Merck & Co. has agreed to acquire Verona Pharma for $10 billion, the companies said, in a deal designed to expand the pharma ...

This acquisition of Verona Pharma reflects the commitment we have to delivering innovative treatments to patients and our ...

The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...